• Back to Butler Hospital
  • +1 (401) 455-6581
Make an Impact

Weld Building Renovation Plans

Butler Hospital will renovate its 120-year-old Weld Building to house a major expansion of the Memory and Aging program. Once completed, the program will expand into 18,000 square feet on three floors to accommodate screenings, therapy infusions, cognitive assessments, and consultations.

The renovation will support Butler’s involvement in an impressive range of trials of new treatments and the development of new diagnostic tools, prevention programs, and awareness programs that help dispel the fear and stigma surrounding Alzheimer’s disease. These programs feature dynamic collaborations with the Alpert Medical School and researchers at hospitals and universities across Rhode Island and the nation.

Give Directly to Our Capital Campaign
Our Financial Goal for the Renovation:

To achieve our vision and goals on behalf of the patients we serve, we will need your help and support. To that end, Butler Hospital, an affiliate of Care New England, will launch a fundraising effort through which we will endeavor to raise as much of the $3 million cost of this essential and extraordinary initiative as possible. Unequivocally, the ultimate success of this philanthropic effort will depend upon your generous philanthropic investment.

“It is a far more exciting time than ever for all of us in the field of memory and aging, because we can see beyond the years of effort to a result: one that we hope will change the lives of many.”

- Stephen Salloway, MD, MS
Professor of Neurology and Psychiatry, Alpert Medical School, and Director, Memory & Aging Program


Butler is at the forefront of significant progress and potential breakthroughs in key areas of memory and aging:
Emtriva Clinical Trials

Currently, we are collaborating with researchers at the Alpert Medical School and Miriam Hospital to conduct a clinical trial on the treatment of Alzheimer’s disease with the drug Emtriva. This trial will be the first of its kind to use this class of drug to reduce inflammation due to cellular aging in the context of Alzheimer’s. 

Aduhelm Clinical Trials

Butler has been active in phase-three clinical trials of Aduhelm, which targets the build-up of amyloid in the brain, long suspected as a cause of Alzheimer’s. A significant expansion of the Weld Building and our infusion capacity will greatly help to address the anticipated high demand for this very hopeful treatment.

Early Detection of Alzheimer’s

Butler is collaborating with researchers at the University of Rhode Island and BayCare  Health System in Florida to launch a clinical trial of retinal screening processes that could help clinicians detect Alzheimer’s disease as much as two or more decades before patients develop life-changing symptoms.

Get In Touch

Butler Hospital Foundation
Major Gifts

Elizabeth Zima
Philanthropy Officer, Major Gifts
P: (401) 681-2855
E: EZima@CareNE.org

Donate to our capital campaign

Your donation will go directly to our Weld Build Renovation